Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×

Online ordering will be unavailable from 17:00 GMT on Friday, April 25 until 17:00 GMT on Sunday, April 27 due to maintenance. We apologise for the inconvenience.

Hostname: page-component-669899f699-b58lm Total loading time: 0 Render date: 2025-04-25T17:17:07.776Z Has data issue: false hasContentIssue false

Chapter 8 - Managing Parkinson’s Disease Patients Treated with Deep Brain Stimulation

Published online by Cambridge University Press:  09 June 2022

By
Sloan Barton ,
Sarah Robbins  and
Rajeev Kumar
Edited by
William J. Marks  and
Jill L. Ostrem
William J. Marks
Affiliation:
Stanford University, California
Jill L. Ostrem
Affiliation:
University of California, San Francisco
Get access

Summary

Deep brain stimulation (DBS) is a widely used treatment for movement disorders inadequately treated with medications, including Parkinson’s disease (PD), dystonia, and various forms of tremor. In this chapter, we focus on what has changed in the past five years in the use of DBS for PD treatment in the context of the basics. This will serve as both an update for the experienced person and a detailed text for the novice. We discuss updates on the new types of approved hardware that have allowed for even greater stimulation options, new information on management of non-motor symptoms associated with DBS, long-term prognosis and outcomes, new data on when to perform surgery, and developments shaping the future of DBS.

Type
Chapter
Information
Deep Brain Stimulation Management , pp. 109 - 142
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Benazzouz, A, Hallett, M. Mechanism of action of deep brain stimulation. Neurology 2000;55 (Suppl 6):13–16.Google Scholar
Benabid, A, Pollak, P, Gervason, C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337(8738):403–406.Google Scholar
Benabid, AL, Chabardes, S, Mitrofanis, J, et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet 2009;8:68–81.Google ScholarPubMed
Tykocki, T, Mandat, T, Nauman, P. Pedunculopontine nucleus deep brain stimulation in Parkinson’s disease. Arch Med Sci 2011;7(4): 555–564.Google Scholar
Plaha, P, Ben-Shlomo, Y, Patel, NK, Gill, SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006;129:1732–1747.Google Scholar
Schuepbach, W, Knudsen, R, Volkmann, J, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 2013;368:610–622.CrossRefGoogle ScholarPubMed
Ngoga, D, Mitchell, R, Kausar, J, et al. Deep brain stimulation improves survival in severe Parkinson’s disease. J Neurol Neurosurg Psychiatry 2014;85:17–22.CrossRefGoogle ScholarPubMed
Merola, A, Zibetti, M, Angrisano, S, et al. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson’s disease. Mov Disord 2011;26:664–670.Google Scholar
Henderson, JM, O’Sullivan, DJ, Pell, M, et al. Lesion of thalamic centromedian-parafascicular complex after chronic deep brain stimulation. Neurology 2001;56:1576–1579.Google Scholar
Deep Brain Stimulation for Parkinson’s Disease Study Group. Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 2001;345:956–963.Google Scholar
Witjas, T, Kaphan, E, Azulay, JP, et al. Effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on non-motor fluctuation (NMF) in Parkinson’s disease. Neurology 2001;56(Suppl 3):274.Google Scholar
Fasano, A, Daniele, A, Albanese, A. Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. Lancet Neurol 2012;11:429–442.Google Scholar
Marques, A, Chassin, O, Morand, D. Central pain modulation after subthalamic nucleus stimulation. Neurology 2013;81(7):633–640.Google Scholar
Sako, W, Nishio, M, Maruo, T, et al. Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson’s disease. Mov Disord 2009;24:1076–1079.Google Scholar
Welter, ML, Houeto, JL, Tezenas du Montcel, S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson’s disease. Brain 2002;125:575–583.Google Scholar
Vingerhoets, FJG, Villemure, JG, Temperli, P, et al. Subthalamic DBS replaces levodopa in Parkinson’s disease: Two-year follow-up. Neurology 2002;58:396–401.CrossRefGoogle ScholarPubMed
Fontaine, D, Mattei, V, Borg, M, et al. Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report. J Neurosurg 2004;100:1084–1086.Google Scholar
Weaver, FM, Follett, KA, Stern, M, et al. Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes. Neurology 2012;79(1):55–65.Google Scholar
Uitti, RJ, Tsuboi, Y, Pooley, RA, et al. Magnetic resonance imaging and deep brain stimulation. Neurosurgery 2002;51:1423–1431.Google Scholar
Larson, PS, Richardson, RM, Starr, PA, et al. Magnetic resonance imaging of implanted deep brain stimulators: Experience in a large series. Stereotact Funct Neurosurg 2008;86:92–100.Google Scholar
Carcieri, S, Reich, M, Steigerwald, F. Impedance changes occur during threshold measurements in deep brain stimulation patients. Neurology 2014;82(Suppl): P7.046.Google Scholar
Krack, P, Pollak, P, Limousin, P, et al. Opposite motor effects of pallidal stimulation in Parkinson’s disease. Ann Neurol 1998;43:180–192.CrossRefGoogle ScholarPubMed
Bejjani, B, Damier, P, Arnulf, I, et al. Pallidal stimulation for Parkinson’s disease. Two targets?Neurology 1997;49(1):564–569.Google Scholar
Deuschl, G, Schade-Brittinger, C, Krack, P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006; 355:896–908.Google Scholar
Castrioto, A, Volkman, J, Krack, P. Postoperative management of deep brain stimulation in Parkinson’s disease. In Lozano, A, Hallett, M, eds. Handbook of Clinical Neurology. Amsterdam: Elsevier B.V.; 2013, 116:129–146.Google Scholar
Castrioto, A, Kistner, A, Klinger, K, et al. Psychostimulant effect of levodopa: Reversing sensitization is possible. J Neurol Neurosurg Psychiatry 2013; 84:18–22.Google Scholar
Kedia, S, Moro, E, Tagliati, M, Lang, AE, Kumar, R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004;63(12):2410–2412.CrossRefGoogle ScholarPubMed
Driver-Dunckley, E, Evidente, VG, Adler, CH, et al. Restless legs syndrome in Parkinson’s disease patients may improve with subthalamic stimulation. Mov Disord 2006;21:1287–1289.CrossRefGoogle ScholarPubMed
Chung, K, Lobb, B, Nutt, J, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010;75:1263–1269.Google Scholar
Khoo, H, Kishima, H, Hosomi, K, et al. Low frequency subthalamic nucleus stimulation in Parkinson’s disease: A randomized clinical trial. Mov Disord 2011;29:270–274.CrossRefGoogle Scholar
Moreau, C, Delval, A, Defebvre, L, et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: A multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol 2012;11:589–596.Google Scholar
Haynes, WI, Haber, SN. The organization of prefrontal–subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: Implications for basal ganglia models and deep brain stimulation. J Neurosci 2013;33:4804–4814.CrossRefGoogle ScholarPubMed
Castrioto, A, Lhommèe, E, Krack, P, et al. Mood and behavioural effects of subthalamic stimulation. Lancet Neurol 2014;13:287–305.Google Scholar
Thobois, S, Ardouin, C, Lhommée, E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: Predictors and underlying mesolimbic denervation. Brain 2010; 133:1111–1127.Google Scholar
Volkmann, J, Daniels, C, Witt, K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 2010;6:487–498.Google Scholar
Bejjani, BP, Damier, P, Arnulf, I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999;340(19):1476–1480.Google Scholar
Voon, V, Krack, P, Lang, AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain 2008;131:2720–2728.CrossRefGoogle ScholarPubMed
Krack, P, Kumar, R, Ardouin, C, et al. Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord 2001;16:867–875.Google Scholar
Frank, M, Samanta, J, Moustafa, A, et al. Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007;318:1309–1312.CrossRefGoogle ScholarPubMed
Lim, SY, O’Sullivan, S, Kotschet, K, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson’s disease. J Clin Neurosci 2009;9:1148–1152.Google Scholar
Wu, B, Han, L, Sun, BM, et al. Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson’s disease. Neurosci Bull 2014;30:153–161.Google Scholar
Witt, K, Daniels, C, Reiff, J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: A randomised, multicentre study. Lancet Neurol 2008;7:605–614.Google Scholar
Witt, K, Granert, O, Daniels, C, et al. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson’s disease: Results from a randomized trial. Brain 2013;136:2109–2119.Google Scholar
Rodriguez-Oroz, MC, Moro, E, Krack, P. Long-term outcomes of surgical therapies for Parkinson’s disease. Mov Disord 2012;27:1718–1728.Google Scholar
Hely, M, Reid, W, Adena, M. The Sydney Multicenter Study of Parkinson’s Disease: The inevitability of dementia at 20 years. Mov Disord 2008;23(6):837–844.Google Scholar
Freund, H, Kuhn, J, Lenartz, D, et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol 2009;66:781–785.CrossRefGoogle Scholar
Stefani, A, Lozano, AM, Peppe, A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 2007;130:1596–1607.CrossRefGoogle ScholarPubMed
Ferraye, M, Debû, B, Fraix, V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson’s disease. Brain 2010;133:205–214.Google Scholar
Hartmann, CJ, et al. An update on the best practice of deep brain stimulation in Parkinson’s disease. Therapeutic Advances in Neurological Disorders, SAGE Publication, 28, Mar. 2019.Google Scholar
Couto, MI, et al. Depression and anxiety following deep brain stimulation in Parkinson’s disease: Systematic review and meta-analysis. Acta Médica Portuguesa 2014;27(3):372–382. doi: 10.20344/amp.4928Google Scholar
Vachez, Y, Carcenac, C, Magnard, R, Kerkerian-Le Goff, L, Salin, P, Savasta, M, Carnicella, S, Boulet, S, Vachez, Y, et al. Subthalamic nucleus stimulation impairs motivation: Implication for apathy in Parkinson’s disease. Movement Disorders 2020;35(4):616–628. doi: 10.1002/mds.27953. Epub 2020 Jan 13.Mov Disord. 2020. PMID: 31930749Google Scholar
Zhang, S, et al. Interleaving subthalamic nucleus deep brain stimulation to avoid side effects while achieving satisfactory motor benefits in Parkinson disease: A report of 12 cases. Medicine, Wolters Kluwer Health, Dec. 2016.Google Scholar
Schüpbach, WM, Chabardes, S, Matthies, C, Pollo, C, Steigerwald, F, Timmermann, L, Visser Vanderwalle, V, Volkmann, J, Schuurmann, PR. Directional leads for deep brain stimulation: Opportunities and challenges. Movement Disorders 2017;32(10):1371–1375. doi: 10.1002/mds.27096.Google Scholar
Fasano, A, et al. Medical management of Parkinson’s disease after initiation of deep brain stimulation. Cambridge Core, Cambridge University Press, July 14, 2016.Google Scholar
Basiago, A, Binder, DK. Effects of deep brain stimulation on autonomic function. Brain Sciences Aug 16;6(3):33. doi: 10.3390/brainsci6030033.Google Scholar
Soh, D, et al. Therapeutic window of deep brain stimulation using cathodic monopolar, bipolar, semi‐bipolar, and anodic stimulation. Neuromodulation: Technology at the Neural Interface 2019;22(4):451–455. doi: 10.1111/ner.12957. Epub 2019 Apr 5.Google Scholar
Anderson, DN, et al. Anodic stimulation misunderstood: Preferential activation of fiber orientations with anodic waveforms in deep brain stimulation. Journal of Neural Engineering 2019;16(1):016026. doi: 10.1088/1741-2552/aae590. Epub 2018 Oct 2Google Scholar
Kirsch, AD, et al. Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects. Parkinsonism & Related Disorders 2018;55:61–67.Google Scholar
Kurtis, MM, et al. The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: A critical review of the current evidence. Nature News, Nature Publishing Group, 12 Jan. 2017.Google Scholar
Kochanski, RB, Sani, S. Awake versus asleep deep brain stimulation surgery: Technical considerations and critical review of the literature. Brain Sci 2018 Jan;8(1):17.Google Scholar
Jung, YJ, Kim, H, Jeon, BS, Park, H, Lee, W, Paek, SH. An 8-year follow-up on the effect of subthalamic nucleus deep brain stimulation on pain in Parkinson disease. JAMA Neurology 2015 May;72(5):504–510. doi: 10.1001/jamaneurol.2015.8Google Scholar
Dimarzio, M, et al. Kings Parkinsons Disease Pain Scale for Assessment of Pain Relief following Deep Brain Stimulation for Parkinsons Disease. Neuromodulation: Technology at the Neural Interface 2018;21(6):617–622.Google Scholar
Demetriades, P, et al. Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: Clinical aspects. Parkinson’s Disease, SAGE-Hindawi Access to Research, 20 Feb. 2011.Google Scholar
Accolla, EA, Pollo, C. Mood effects after deep brain stimulation for Parkinson’s disease: An update. Frontiers in Neurology, Frontiers Media S.A., 14 June 2019.Google Scholar
Merola, A, Romagnolo, A, Krishna, V, et al. Current directions in deep brain stimulation for Parkinson’s disease: Directing current to maximize clinical benefit. Neurol Ther 2020; 9:25–41.Google Scholar
Růžička, F, et al. Weight gain is associated with medial contact site of subthalamic stimulation in Parkinson’s disease. PloS One, Public Library of Science, 2012.Google Scholar
Regidor, I, et al. Duodenal levodopa infusion for long-term deep brain stimulation: Refractory symptoms in advanced Parkinson disease. Clinical Neuropharmacology 2017;40(3):103–107.Google Scholar
Kim, HJ, and Jeon, B. Decision under risk: Argument against early deep brain stimulation in Parkinsons disease. Parkinsonism & Related Disorders 2019;69:7–10.Google Scholar
Wu, C, Sharan, A. Deep brain stimulation: Awake and asleep options. JHN Journal 2016;11(2).Google Scholar
Bouthour, W, et al. Dyskinesia‐inducing lead contacts optimize outcome of subthalamic stimulation in Parkinsons disease. Movement Disorders 2019;34(11):1728–1734.Google Scholar
Arlotti, M, et al. Eight-hours adaptive deep brain stimulation in patients with Parkinson disease. Neurology 2018;90(11):e971–e976. doi: 10.1212/WNL.0000000000005121. Epub 2018 Feb 14.Neurology. 2018. PMID: 29444973Google Scholar
Duchin, Y, et al. Patient-specific anatomical model for deep brain stimulation based on 7 Tesla MRI. Plos One 2018;13(8). doi:10.1371/journal.pone.0201469Google Scholar
Wong, JK, et al. A comprehensive review of brain connectomics and imaging to improve deep brain stimulation outcomes. Movement Disorders 2020;35(5):741–751. doi:10.1002/mds.28045Google Scholar
Krauss, JK, et al. Technology of deep brain stimulation: Current status and future directions. Nature Reviews Neurology 2020;17(2):75–87. doi:10.1038/s41582-020-00426-zGoogle Scholar
Mosley, P, et al. The structural connectivity of subthalamic deep brain stimulation correlates with impulsivity in Parkinson. Brain 2020;143:2235–2254.Google Scholar
Karl, JA, et al. A novel dual-frequency deep brain stimulation paradigm for Parkinson’s disease. Neurology and Therapy 2019;8(2):483–489. doi:10.1007/s40120-019-0140-5Google Scholar
Krüger, MT, et al. Evaluation of automatic segmentation of thalamic nuclei through clinical effects using directional deep brain stimulation leads: A technical note. Brain Sciences 2020;10(9):642. doi:10.3390/brainsci10090642Google Scholar
Abbott Educational Supplement. Issuu. issuu.com/bibapublishing/docs/abbott_supplement_2019_online?e=33910218/75968233Google Scholar
Fabbri, M, et al. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson’s Disease patients with dysarthria? Parkinsonism & Related Disorders. US National Library of Medicine, July 2019. www.ncbi.nlm.nih.gov/pubmed/31060986Google Scholar
Heusinkveld, LE, Hacker, ML, Turchan, M, Davis, TL, Charles, D. Impact of tremor on patients with early stage Parkinson’s disease. Frontiers in Neurology. US National Library of Medicine. pubmed.ncbi.nlm.nih.gov/30123178Google Scholar
Hacker, ML, et al. Subthalamic nucleus deep brain stimulation may reduce medication costs in early stage Parkinson’s disease. Journal of Parkinsons Disease 2016;6(1):125–131. doi:10.3233/jpd-150712Google Scholar
Medtronic launches first-of-its-kind adaptive deep brain stimulation (ADBS) trial in Parkinson’s disease patients. Medtronic News. news.medtronic.com/2021–01–14-Medtronic-Launches-First-of-Its-Kind-Adaptive-Deep-Brain-Stimulation-aDBS-Trial-in-Parkinsons-Disease-PatientsGoogle Scholar
Paff, M, et al. Update on current technologies for deep brain stimulation in Parkinson’s disease. Journal of Movement Disorders 2020:13(3):185–198. doi:10.14802/jmd.20052Google Scholar
Daniels, C, et al. Combined subthalamic and nucleus basalis of Meynert Deep Brain Stimulation for Parkinson’s Disease with Dementia (DEMPARK-DBS): Protocol of a randomized, sham-controlled trial. Neurological Research and Practice 2020;2(1). doi:10.1186/s42466-020-00086-wGoogle Scholar
Dafsari, HS et al. Beneficial effects of bilateral subthalamic stimulation on non-motor symptoms in Parkinson’s disease. Brain Stimul 2016;9:78–85.Google Scholar
Iranzo, A, Valldeoriola, F, Santamaría, J, Tolosa, E, Rumià, J. Sleep symptoms and polysomnographic architecture in advanced Parkinson’s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002 ;72:661–664.CrossRefGoogle ScholarPubMed
Zibetti, M, et al. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007;58:218–223.Google Scholar
Troche, MS, Brandimore, AE, Foote, KD, Okun, MS. Swallowing and deep brain stimulation in Parkinson’s disease: A systematic review. Parkinsonism Relat Disord 2013;19:783–788.Google Scholar
Derrey, S, et al. Impact of deep brain stimulation on pharyngo-esophageal motility: A randomized cross-over study. Neurogastroenterol Motil 2015;27:1214–1222.Google Scholar
Strowd, RE, et al. Association between subthalamic nucleus deep brain stimulation and weight gain: Results of a case-control study. Clin Neurol Neurosurg 2016;140:38–42.Google Scholar
Foubert-Samier, A, et al. A long-term follow-up of weight changes in subthalamic nucleus stimulated Parkinson’s disease patients. Rev Neurol 2012;168:173–176.Google Scholar
Seif, C, et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 2004;55:118–120.Google Scholar
Herzog, J. et al. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson’s disease. Brain 2006;129:3366–3375.Google Scholar
Kern, DS, Picillo, M, Thompson, JA, Sammartino, F, di Biase, L, Munhoz, RP, Fasano, A. Interleaving stimulation in Parkinson’s disease, tremor, and dystonia. Stereotactic and Functional Neurosurgery 2018;96(6):379–391. doi:10.1159/000494983. Epub 2019 Jan 17.CrossRefGoogle ScholarPubMed
Chastan, N, Westby, GWM, Yelnik, J, et al. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson’s disease. Brain 2009;132(1):172–184.Google Scholar
Weiss, D, Walach, M, Meisner, C, et al., Nigral stimulation for resistant axial motor impairment in Parkinson’s disease: A randomized controlled trial. Brain 2013;136(7):2098–2108.Google Scholar
Odekerken, VJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): A randomised controlled trial. Lancet Neurol 2013;12:37–44.Google Scholar
Dayal, V, Grover, T, Tripoliti, E, et al. Short versus conventional pulse‐width deep brain stimulation in Parkinson’s disease: A randomized crossover comparison. Movement Disorders;2019. mds.27863–. doi:10.1002/mds.27863Google Scholar
Musacchio, T, Rebenstorff, M, Fluri, F, Brotchie, JM, Volkmann, J, Koprich, JB, Ip, CW. STN-DBS is neuroprotective in the A53T α-synuclein Parkinson’s disease rat model. Annals of Neurology;2019. doi:10.1002/ana.24947Google Scholar
Grossman, N, Bono, D, Dedic, N, Kodandaramaiah, SB, Rudenko, A, Suk, HJ, et al. Noninvasive deep brain stimulation via temporally interfering electric fields. Cell 2017;169:1029–1041.Google Scholar
Saint-Cyr, JA, Trépanier, LL, Kumar, R, et al. Neuropsychological consequences of chronic bilateral stimulationof the subthalamic nucleus in Parkinson’s disease. Brain 2000;123:2091–2108.Google Scholar
Brodsky, MA, Anderson, S, Murchison, C, Seier, M, Wilhelm, J, Vederman, A, Burchiel, KJ. Clinical outcomes of asleep vs. awake deep brain stimulation for Parkinson disease. Neurology 2017;89:1944–1950.Google Scholar
Stemper, B. et al. Deep brain stimulation improves orthostatic regulation of patients with Parkinson disease. Neurology 2006;67:1781–1785.Google Scholar
Kim, YE, et al. Impulse control and related behaviors after bilateral subthalamic stimulation in patients with Parkinson’s disease. J Clin Neurosci 2013;20:964–969.Google Scholar
Czernecki, V, Schüpbach, M, Sadek, Y, et al. Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom. Mov Disord 2008 May 15;23(7):964–969.Google Scholar
Sankary, LR, Ford, PJ, Machado, AG, et al. Deep brain stimulation at end of life: Clinical and ethical Considerations. J Palliat Med 2020 Apr;23(4):582–585.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×